Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas.
Chiappa M, Decio A, Guarrera L, Mengoli I, Karki A, Yemane D, Ghilardi C, Scanziani E, Canesi S, Barbera MC, Craparotta I, Bolis M, Fruscio R, Grasselli C, Ceruti T, Zucchetti M, Patterson JC, Lu RA, Yaffe MB, Ridinger M, Damia G, Guffanti F.
Chiappa M, et al. Among authors: barbera mc.
Cell Death Dis. 2024 Jul 22;15(7):521. doi: 10.1038/s41419-024-06894-1.
Cell Death Dis. 2024.
PMID: 39039067
Free PMC article.